Literature DB >> 30465211

Establishment of Slice Cultures as a Tool to Study the Cancer Immune Microenvironment.

Xiuyun Jiang1, Y David Seo1, Kevin M Sullivan1, Venu G Pillarisetty2.   

Abstract

Although immunotherapy is currently being widely applied to treat a variety of cancers, there is great heterogeneity in the response to these treatments. Many in the field hypothesize that this may be attributable to the characteristics of each individual tumor immune microenvironment, in addition to systemic immune factors. Therefore, understanding the immune cell microenvironment in a variety of tumors is critically important. Specifically, the interactions among immune, stromal, and cancer cells, along with other factors in tumors, may hold the key to developing rational personalized combinations of immunotherapeutic drugs. We recently developed an organotypic slice culture technique, which enables precise study of the pancreatic ductal adenocarcinoma (PDA) tumor microenvironment. We used a Vibratome to cut fresh human tumor tissue into 250 μm thick slices, and cultured slices on cell culture inserts with 0.4 μm pore to produce our tumor slice culture (TSC) system. We showed that TSC maintained many elements of the original tumor microenvironment and architecture for approximately one week. Using this slice culture technique for PDA, we demonstrated that immune cells, including T cells and macrophages, cancer cells, and stromal myofibroblasts were present throughout the culture period. TSCs were functionally responsive to drug treatment. Live PDA slices could be stained for multicolor immunofluorescence imaging of each of the primary cellular constituents of the tumor. Finally, autologous CFSE-labeled splenocytes were observed to readily migrate into cocultured tumor slices.

Entities:  

Keywords:  Immune cells; Slice culture; TME; Tool; Tumor microenvironment

Mesh:

Substances:

Year:  2019        PMID: 30465211     DOI: 10.1007/978-1-4939-8885-3_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Patient-Derived Breast Cancer Tissue Cultures for Anti-Endocrine Drug Assays.

Authors:  Giacomo Domenici; Gonçalo Trindade; Marta F Estrada; Ana Luísa Cartaxo; Paula M Alves; Saudade André; Catarina Brito
Journal:  Methods Mol Biol       Date:  2022

2.  Calcium channel blockers potentiate gemcitabine chemotherapy  in pancreatic cancer.

Authors:  Daniel R Principe; Alexandre F Aissa; Sandeep Kumar; Thao N D Pham; Patrick W Underwood; Rakesh Nair; Rong Ke; Basabi Rana; Jose G Trevino; Hidayatullah G Munshi; Elizaveta V Benevolenskaya; Ajay Rana
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-27       Impact factor: 12.779

3.  Hypoxia-inducible lentiviral gene expression in engineered human macrophages.

Authors:  Harrison K Chinn; Jennifer L Gardell; Lisa R Matsumoto; Kevin P Labadie; Tara N Mihailovic; Nicole A P Lieberman; Amira Davis; Venu G Pillarisetty; Courtney A Crane
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

Review 4.  Patient-derived tumour models for personalized therapeutics in urological cancers.

Authors:  Arjanneke F van de Merbel; Geertje van der Horst; Gabri van der Pluijm
Journal:  Nat Rev Urol       Date:  2020-11-10       Impact factor: 14.432

5.  Engineering T cells to enhance 3D migration through structurally and mechanically complex tumor microenvironments.

Authors:  Erdem D Tabdanov; Nelson J Rodríguez-Merced; Alexander X Cartagena-Rivera; Vikram V Puram; Mackenzie K Callaway; Ethan A Ensminger; Emily J Pomeroy; Kenta Yamamoto; Walker S Lahr; Beau R Webber; Branden S Moriarity; Alexander S Zhovmer; Paolo P Provenzano
Journal:  Nat Commun       Date:  2021-05-14       Impact factor: 14.919

Review 6.  Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development.

Authors:  Bernarda Majc; Metka Novak; Nataša Kopitar-Jerala; Anahid Jewett; Barbara Breznik
Journal:  Cells       Date:  2021-01-29       Impact factor: 6.600

Review 7.  Temporal single-cell regeneration studies: the greatest thing since sliced pancreas?

Authors:  Juan Domínguez-Bendala; Mirza Muhammad Fahd Qadir; Ricardo Luis Pastori
Journal:  Trends Endocrinol Metab       Date:  2021-05-15       Impact factor: 10.586

8.  Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery.

Authors:  Ramya Sivakumar; Marina Chan; Jiye Stella Shin; Nao Nishida-Aoki; Heidi L Kenerson; Olivier Elemento; Himisha Beltran; Raymond Yeung; Taranjit S Gujral
Journal:  Oncoimmunology       Date:  2019-10-10       Impact factor: 8.110

Review 9.  Does the Microenvironment Hold the Hidden Key for Functional Precision Medicine in Pancreatic Cancer?

Authors:  John Kokkinos; Anya Jensen; George Sharbeen; Joshua A McCarroll; David Goldstein; Koroush S Haghighi; Phoebe A Phillips
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

10.  Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses.

Authors:  Katherine J Brempelis; Courtney M Cowan; Shannon A Kreuser; Kevin P Labadie; Brooke M Prieskorn; Nicole A P Lieberman; Chibawanye I Ene; Kara W Moyes; Harrison Chinn; Kole R DeGolier; Lisa R Matsumoto; Sara K Daniel; Jason K Yokoyama; Amira D Davis; Virginia J Hoglund; Kimberly S Smythe; Stephanie D Balcaitis; Michael C Jensen; Richard G Ellenbogen; Jean S Campbell; Robert H Pierce; Eric C Holland; Venu G Pillarisetty; Courtney A Crane
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.